One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.
Identifieur interne : 000025 ( Main/Exploration ); précédent : 000024; suivant : 000026One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.
Auteurs : Charlotte Moss [Royaume-Uni] ; Saoirse Dolly [Royaume-Uni] ; Beth Russell [Royaume-Uni] ; Mary Lei [Royaume-Uni] ; Sharmista Ghosh [Royaume-Uni] ; Sophie Papa [Royaume-Uni] ; Richard Sullivan [Royaume-Uni] ; Mieke Van Hemelrijck [Royaume-Uni] ; Anne Rigg [Royaume-Uni]Source :
- Cancer control : journal of the Moffitt Cancer Center [ 1526-2359 ]
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Betacoronavirus (isolement et purification), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (diagnostic), Infections à coronavirus (épidémiologie), Londres (épidémiologie), Mâle (MeSH), Pandémies (MeSH), Pneumopathie virale (diagnostic), Pneumopathie virale (épidémiologie), Prévalence (MeSH), Sujet âgé (MeSH), Tumeurs (thérapie), Tumeurs (épidémiologie), Établissements de cancérologie (MeSH).
- MESH :
- diagnostic : Infections à coronavirus, Pneumopathie virale.
- isolement et purification : Betacoronavirus.
- thérapie : Tumeurs.
- épidémiologie : Infections à coronavirus, Londres, Pneumopathie virale, Tumeurs.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Mâle, Pandémies, Prévalence, Sujet âgé, Établissements de cancérologie.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Betacoronavirus (isolation & purification), Cancer Care Facilities (MeSH), Coronavirus Infections (diagnosis), Coronavirus Infections (epidemiology), Female (MeSH), Humans (MeSH), London (epidemiology), Male (MeSH), Middle Aged (MeSH), Neoplasms (epidemiology), Neoplasms (therapy), Pandemics (MeSH), Pneumonia, Viral (diagnosis), Pneumonia, Viral (epidemiology), Prevalence (MeSH).
- MESH :
- geographic , epidemiology : London.
- diagnosis : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Neoplasms, Pneumonia, Viral.
- isolation & purification : Betacoronavirus.
- therapy : Neoplasms.
- Adult, Aged, Cancer Care Facilities, Female, Humans, Male, Middle Aged, Pandemics, Prevalence.
Abstract
COVID-19 has forced governments to make drastic changes to healthcare systems. To start making informed decisions about cancer care, we need to understand the scale of COVID-19 infection. Therefore, we introduced swab testing for patients visiting Guy's Cancer Centre. Our Centre is one of the largest UK Cancer Centers at the epicenter of the UK COVID-19 epidemic. The first COVID-19 positive cancer patient was reported on 29 February 2020. We analyzed data from 7-15 May 2020 for COVID-19 tests in our cancer patients. 2,647 patients attended for outpatient, chemotherapy, or radiotherapy appointments. 654 were swabbed for COVID-19 (25%). Of those tested, 9 were positive for COVID-19 (1.38%) of which 7 were asymptomatic. Cancer service providers will need to understand their local cancer population prevalence. The absolute priority is that cancer patients have the confidence to attend hospitals and be reassured that they will be treated in a COVID-19 managed environment.
DOI: 10.1177/1073274820950844
PubMed: 32885663
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.</title><author><name sortKey="Moss, Charlotte" sort="Moss, Charlotte" uniqKey="Moss C" first="Charlotte" last="Moss">Charlotte Moss</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Dolly, Saoirse" sort="Dolly, Saoirse" uniqKey="Dolly S" first="Saoirse" last="Dolly">Saoirse Dolly</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Russell, Beth" sort="Russell, Beth" uniqKey="Russell B" first="Beth" last="Russell">Beth Russell</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Lei, Mary" sort="Lei, Mary" uniqKey="Lei M" first="Mary" last="Lei">Mary Lei</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Ghosh, Sharmista" sort="Ghosh, Sharmista" uniqKey="Ghosh S" first="Sharmista" last="Ghosh">Sharmista Ghosh</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Papa, Sophie" sort="Papa, Sophie" uniqKey="Papa S" first="Sophie" last="Papa">Sophie Papa</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Sullivan, Richard" sort="Sullivan, Richard" uniqKey="Sullivan R" first="Richard" last="Sullivan">Richard Sullivan</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Van Hemelrijck, Mieke" sort="Van Hemelrijck, Mieke" uniqKey="Van Hemelrijck M" first="Mieke" last="Van Hemelrijck">Mieke Van Hemelrijck</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Rigg, Anne" sort="Rigg, Anne" uniqKey="Rigg A" first="Anne" last="Rigg">Anne Rigg</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Jul-Aug</date><idno type="RBID">pubmed:32885663</idno><idno type="pmid">32885663</idno><idno type="doi">10.1177/1073274820950844</idno><idno type="wicri:Area/Main/Corpus">000346</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000346</idno><idno type="wicri:Area/Main/Curation">000346</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000346</idno><idno type="wicri:Area/Main/Exploration">000346</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.</title><author><name sortKey="Moss, Charlotte" sort="Moss, Charlotte" uniqKey="Moss C" first="Charlotte" last="Moss">Charlotte Moss</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Dolly, Saoirse" sort="Dolly, Saoirse" uniqKey="Dolly S" first="Saoirse" last="Dolly">Saoirse Dolly</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Russell, Beth" sort="Russell, Beth" uniqKey="Russell B" first="Beth" last="Russell">Beth Russell</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Lei, Mary" sort="Lei, Mary" uniqKey="Lei M" first="Mary" last="Lei">Mary Lei</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Ghosh, Sharmista" sort="Ghosh, Sharmista" uniqKey="Ghosh S" first="Sharmista" last="Ghosh">Sharmista Ghosh</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Papa, Sophie" sort="Papa, Sophie" uniqKey="Papa S" first="Sophie" last="Papa">Sophie Papa</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Sullivan, Richard" sort="Sullivan, Richard" uniqKey="Sullivan R" first="Richard" last="Sullivan">Richard Sullivan</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Van Hemelrijck, Mieke" sort="Van Hemelrijck, Mieke" uniqKey="Van Hemelrijck M" first="Mieke" last="Van Hemelrijck">Mieke Van Hemelrijck</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Rigg, Anne" sort="Rigg, Anne" uniqKey="Rigg A" first="Anne" last="Rigg">Anne Rigg</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><series><title level="j">Cancer control : journal of the Moffitt Cancer Center</title><idno type="eISSN">1526-2359</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Betacoronavirus (isolation & purification)</term><term>Cancer Care Facilities (MeSH)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (epidemiology)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>London (epidemiology)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Neoplasms (epidemiology)</term><term>Neoplasms (therapy)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (epidemiology)</term><term>Prevalence (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Betacoronavirus (isolement et purification)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (diagnostic)</term><term>Infections à coronavirus (épidémiologie)</term><term>Londres (épidémiologie)</term><term>Mâle (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (diagnostic)</term><term>Pneumopathie virale (épidémiologie)</term><term>Prévalence (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Tumeurs (thérapie)</term><term>Tumeurs (épidémiologie)</term><term>Établissements de cancérologie (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>London</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Neoplasms</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Londres</term><term>Pneumopathie virale</term><term>Tumeurs</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Cancer Care Facilities</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Prevalence</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Pandémies</term><term>Prévalence</term><term>Sujet âgé</term><term>Établissements de cancérologie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">COVID-19 has forced governments to make drastic changes to healthcare systems. To start making informed decisions about cancer care, we need to understand the scale of COVID-19 infection. Therefore, we introduced swab testing for patients visiting Guy's Cancer Centre. Our Centre is one of the largest UK Cancer Centers at the epicenter of the UK COVID-19 epidemic. The first COVID-19 positive cancer patient was reported on 29 February 2020. We analyzed data from 7-15 May 2020 for COVID-19 tests in our cancer patients. 2,647 patients attended for outpatient, chemotherapy, or radiotherapy appointments. 654 were swabbed for COVID-19 (25%). Of those tested, 9 were positive for COVID-19 (1.38%) of which 7 were asymptomatic. Cancer service providers will need to understand their local cancer population prevalence. The absolute priority is that cancer patients have the confidence to attend hospitals and be reassured that they will be treated in a COVID-19 managed environment.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32885663</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-2359</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>3</Issue><PubDate><MedlineDate>2020 Jul-Aug</MedlineDate></PubDate></JournalIssue><Title>Cancer control : journal of the Moffitt Cancer Center</Title><ISOAbbreviation>Cancer Control</ISOAbbreviation></Journal><ArticleTitle>One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.</ArticleTitle><Pagination><MedlinePgn>1073274820950844</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1073274820950844</ELocationID><Abstract><AbstractText>COVID-19 has forced governments to make drastic changes to healthcare systems. To start making informed decisions about cancer care, we need to understand the scale of COVID-19 infection. Therefore, we introduced swab testing for patients visiting Guy's Cancer Centre. Our Centre is one of the largest UK Cancer Centers at the epicenter of the UK COVID-19 epidemic. The first COVID-19 positive cancer patient was reported on 29 February 2020. We analyzed data from 7-15 May 2020 for COVID-19 tests in our cancer patients. 2,647 patients attended for outpatient, chemotherapy, or radiotherapy appointments. 654 were swabbed for COVID-19 (25%). Of those tested, 9 were positive for COVID-19 (1.38%) of which 7 were asymptomatic. Cancer service providers will need to understand their local cancer population prevalence. The absolute priority is that cancer patients have the confidence to attend hospitals and be reassured that they will be treated in a COVID-19 managed environment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moss</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolly</LastName><ForeName>Saoirse</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Sharmista</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papa</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Hemelrijck</LastName><ForeName>Mieke</ForeName><Initials>M</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-7317-0858</Identifier><AffiliationInfo><Affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigg</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Guy’s Cancer Real World Evidence Programme</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Control</MedlineTA><NlmUniqueID>9438457</NlmUniqueID><ISSNLinking>1073-2748</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002173" MajorTopicYN="N">Cancer Care Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008131" MajorTopicYN="N" Type="Geographic">London</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">UK</Keyword><Keyword MajorTopicYN="N">cancer recovery</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32885663</ArticleId><ArticleId IdType="doi">10.1177/1073274820950844</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Moss, Charlotte" sort="Moss, Charlotte" uniqKey="Moss C" first="Charlotte" last="Moss">Charlotte Moss</name></region><name sortKey="Dolly, Saoirse" sort="Dolly, Saoirse" uniqKey="Dolly S" first="Saoirse" last="Dolly">Saoirse Dolly</name><name sortKey="Ghosh, Sharmista" sort="Ghosh, Sharmista" uniqKey="Ghosh S" first="Sharmista" last="Ghosh">Sharmista Ghosh</name><name sortKey="Lei, Mary" sort="Lei, Mary" uniqKey="Lei M" first="Mary" last="Lei">Mary Lei</name><name sortKey="Papa, Sophie" sort="Papa, Sophie" uniqKey="Papa S" first="Sophie" last="Papa">Sophie Papa</name><name sortKey="Papa, Sophie" sort="Papa, Sophie" uniqKey="Papa S" first="Sophie" last="Papa">Sophie Papa</name><name sortKey="Rigg, Anne" sort="Rigg, Anne" uniqKey="Rigg A" first="Anne" last="Rigg">Anne Rigg</name><name sortKey="Russell, Beth" sort="Russell, Beth" uniqKey="Russell B" first="Beth" last="Russell">Beth Russell</name><name sortKey="Sullivan, Richard" sort="Sullivan, Richard" uniqKey="Sullivan R" first="Richard" last="Sullivan">Richard Sullivan</name><name sortKey="Van Hemelrijck, Mieke" sort="Van Hemelrijck, Mieke" uniqKey="Van Hemelrijck M" first="Mieke" last="Van Hemelrijck">Mieke Van Hemelrijck</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000025 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000025 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32885663
|texte= One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32885663" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidSeniorV1
| This area was generated with Dilib version V0.6.37. |  |